Determinants of total and inhaled allergen-specific immunoglobulin E in the middle-aged and elderly population

This study of the Rotterdam Study cohort identifies age, sex, smoking status, BMI, season, and corticosteroid use as key determinants of total and inhaled allergen-specific IgE levels in middle-aged and elderly adults, suggesting that accounting for these factors can improve the clinical interpretation of IgE for allergic conditions.

The Gist

Imagine your immune system as a massive, bustling factory. Inside this factory, there are tiny workers called IgE antibodies. These workers are like specialized security guards. Their main job is to spot "invaders" like pollen, dust mites, or pet dander and sound the alarm. Sometimes, they get a little too excited and cause allergies, but they are also part of the body's defense against parasites.

This paper is like a detective story where researchers went into a giant library of health records (the Rotterdam Study) to figure out what makes these IgE security guards more or less active in middle-aged and elderly people. They looked at two types of guards:

1. Total IgE (tIgE): The total number of guards on duty, regardless of what they are watching.
2. Specific IgE (sIgE): The guards specifically trained to watch for inhaled allergens (like pollen or dust).

Here is what the researchers found, explained through simple analogies:

1. The Age Curve: A "U" and an "L"

The researchers found that age changes the factory's output in two different ways:

• For Total Guards (tIgE): The relationship is shaped like a U. As people get older (up to about 70), the number of guards actually decreases. But once people pass 70, the number starts to climb again. It's like a factory that slows down production in middle age but ramps it up again in very old age.
• For Specific Guards (sIgE): The relationship is shaped like an L. As people get older, the number of guards specifically trained for allergens drops sharply at first and then levels off. It's as if the factory stops training new "allergen specialists" as people age, perhaps because the body has already learned to tolerate these common things over a lifetime.

2. The Gender Gap

• Women generally had fewer total IgE guards than men.
• However, for the specific allergen guards, women also had slightly fewer, though the difference was smaller.
• The researchers noted an interesting "what-if" scenario: While not statistically proven, the data hinted that as men get very old (over 70), their total guard numbers might rise faster than women's.

3. The Smoke Signal

Smoking had a split personality:

• Current Smokers: Had more total IgE guards. The researchers suggest the smoke might be irritating the factory, causing it to overproduce general security.
• Smokers (Current and Former): Had fewer specific allergen guards. This is a bit tricky. The researchers suggest it might be "reverse causation": perhaps people who are prone to strong allergic reactions (and thus have high specific IgE) are less likely to start smoking or are more likely to quit because smoking makes their allergies worse.

4. The Weight Factor

• Higher BMI (Body Mass Index): Was linked to having more total IgE guards. The researchers compare this to a factory running a "pro-inflammatory" state, where the body is slightly stressed, leading to more general security production.
• BMI: Did not seem to change the number of specific allergen guards.

5. The Medicine Paradox (Corticosteroids)

This was a surprising finding. Usually, we think of corticosteroids (like asthma inhalers or skin creams) as "fire extinguishers" that calm down the immune system.

• The Finding: People using topical (skin) or inhaled (breathing) corticosteroids actually had higher levels of both total and specific IgE.
• The Explanation: The researchers suggest this might not be the medicine causing the rise. Instead, people who need these medicines likely have more severe allergies or asthma to begin with. The medicine is the result of the high IgE, not the cause. It's like seeing more fire trucks at a building and assuming the trucks caused the fire, when really the fire caused the trucks to be there.
• Oral Steroids: Taking steroids by mouth didn't show a clear link to IgE levels.
• Long-term check: When they looked at people over time, the amount of steroids they took didn't significantly change their IgE levels up or down.

6. The Seasons

• Total IgE: Was slightly higher in Autumn and Winter compared to Spring.
• Specific IgE: Didn't change much with the seasons.
• The researchers note this is interesting because different allergens peak at different times, but their "mixture" test didn't show a strong seasonal swing for specific guards.

7. Time Travel (Longitudinal Study)

The researchers followed a smaller group of people over about 5.5 years.

• The Result: Both total and specific IgE levels decreased slightly over time.
• The Takeaway: Even without changing their habits, as these middle-aged and elderly people aged a bit more, their IgE levels naturally drifted downward.

Summary

This study is like a map showing that your IgE levels aren't random; they are influenced by your age, gender, smoking habits, weight, and even the season. The researchers emphasize that if doctors want to interpret IgE test results correctly in older adults, they need to consider these factors. For example, knowing that IgE naturally drops after age 70 or that smokers might have different baseline levels helps avoid misdiagnosing a healthy person as having an allergy, or vice versa.

Important Note: The paper explicitly states these findings are for understanding the determinants (causes/associations) of IgE levels. It does not claim these findings should immediately change how doctors treat patients, but rather that these factors should be considered when interpreting test results.

Technical Summary

Technical Summary: Determinants of Total and Inhaled Allergen-Specific Immunoglobulin E in the Middle-Aged and Elderly Population

Problem Statement
Immunoglobulin E (IgE) is a critical biomarker for diagnosing and managing allergic and IgE-related conditions, with emerging evidence linking it to chronic diseases such as cancer, cardiovascular disease, and neurodegenerative disorders. However, the determinants of total IgE (tIgE) and inhaled allergen-specific IgE (sIgE) remain poorly understood, particularly in middle-aged and elderly populations. Existing literature is often limited by small sample sizes, a focus on children or atopic individuals, and inconsistencies in measurement. Furthermore, the specific influence of non-modifiable factors (age, sex, season) and modifiable factors (smoking, alcohol, BMI, corticosteroid use) on IgE levels in the general aging population requires clarification to improve clinical interpretation and future research into causal relationships with chronic disease.

Methodology
This study utilized cross-sectional and longitudinal data from the Rotterdam Study, a large, population-based cohort of middle-aged and elderly residents in the Netherlands.

• Study Population: The analysis included 8,679 participants for cross-sectional assessment (mean age 64.2 years) and a subset of 478 participants with repeated measurements for longitudinal analysis.
• Exposures (Determinants): The study investigated age, sex, smoking status, alcohol consumption, Body Mass Index (BMI), season of blood sampling, and corticosteroid use (topical, inhaled, and oral). Corticosteroid use was categorized by Defined Daily Dose (DDD), with longitudinal analysis utilizing cumulative DDD per year (cDDD/year).
• Outcomes: Serum tIgE and sIgE levels were measured using the NOVEOS fully automated chemiluminescent immunoassay system. tIgE >100 kU/L was considered elevated; sIgE ≥1 Standard Arbitrary Unit (SAU) indicated sensitization to a mixture of inhaled allergens.
• Statistical Analysis:
  • Cross-sectional: Multivariable linear regression models were used with log-transformed tIgE and sIgE to ensure normally distributed residuals. Nonlinearity in age was assessed using restricted cubic splines.
  • Longitudinal: Linear mixed models assessed changes in IgE levels over time and dose-response effects of corticosteroids.
  • Sensitivity Analyses: The study employed Tobit regression to account for tIgE values below the detection limit, inverse probability weighting (IPW) for longitudinal selection bias, and stratification to assess batch and cohort effects.

Key Results

• Age: A nonlinear relationship was observed. tIgE exhibited a U-shaped relationship with age (decreasing until ~70 years, then increasing), while sIgE showed an L-shaped relationship (decreasing with age, particularly in younger cohorts).
• Sex: Women had significantly lower tIgE (OR 0.69) and sIgE (OR 0.96) compared to men.
• Smoking: Current smokers had higher tIgE (OR 1.34) but lower sIgE (OR 0.72) compared to never smokers. Former smokers also showed lower sIgE.
• BMI: Higher BMI was associated with higher tIgE (OR 1.01 per unit) but showed no significant association with sIgE.
• Corticosteroids: Both topical and inhaled corticosteroid use were associated with higher levels of both tIgE and sIgE. Oral corticosteroid use showed no significant association with either outcome.
• Season: tIgE levels were higher in autumn and winter compared to spring; no significant seasonal variation was found for sIgE.
• Alcohol: No significant associations were found between alcohol consumption and either tIgE or sIgE.
• Longitudinal Changes: Over a median follow-up of 5.56 years, both tIgE and sIgE levels decreased significantly. No significant dose-response effect of inhaled or oral corticosteroids on the change in IgE levels was detected, though patterns suggested potential increases with high-dose inhaled use.

Significance and Claims
The authors claim this is the first study to investigate the determinants of both tIgE and sIgE in a large, general population-based cohort of middle-aged and elderly adults. By utilizing advanced immunoassays and modeling age as a continuous variable with nonlinearity assessment, the study provides new insights into the regulation of IgE in aging populations.

The paper posits that incorporating identified determinants—specifically age, sex, smoking, BMI, season, and corticosteroid use—into clinical practice may improve the interpretation of IgE levels for the diagnosis and management of allergic and IgE-related conditions. Furthermore, the authors state that accounting for these factors is essential for future research investigating the causal relationships between IgE and chronic diseases. The study concludes that while these determinants shape IgE levels, the mechanisms (such as age-related immune remodeling or proinflammatory states) warrant further investigation to fully understand their impact on health outcomes in the elderly.